(“SEEIT” or the “Company”) Interim Dividend Declaration
SDCL Energy Efficiency Income Trust plc is pleased to announce the first quarterly interim dividend in respect of the year ending 31 March 2025 of 1.58 pence per Ordinary Share, covered by net operational cash received from investments.
The shares will go ex-dividend on 12 September 2024 and the dividend will be paid on 27 September 2024 to shareholders on the register as at the close of business on 13 September 2024.
££££££££££££
Now just waiting for SOHO to declare their next dividend.
Hey there! Would you mind if I share your blog with my myspace group? There’s a lot of folks that I think would really enjoy your content. Please let me know. Many thanks
Supermarket Income REIT plc (LSE: SUPR), the real estate investment trust providing secure, inflation-linked, long income from grocery property, has today declared an interim dividend in respect of the period from 1 April 2024 to 30 June 2024 of 1.515 pence per ordinary share (the “Fourth Quarterly Dividend”).
The Fourth Quarterly Dividend will be paid on or around 16 August 2024 as a Property Income Distribution (“PID”) in respect of the Company’s tax-exempt property rental business to shareholders on the register as of 12 July 2024. The ex-dividend date will be 11 July 2024.
The Company has now declared four quarterly dividends totalling 6.06 pence per ordinary share in respect of the financial year ended 30 June 2024, in line with the Company’s full-year dividend target.
2 high-yield shares I’d consider to target a £1,380 passive income in 2025
by The Motley Fool
With 2025 just around the corner, I’m looking for high-yield shares to buy that could net me a large passive income.
Dividends are never, ever guaranteed. But if broker forecasts prove accurate, a £20,000 lump sum invested equally in these stocks could net me a £1,380 second income next year.
I’m not just interest in buying stocks for large near-term dividends. I’m also seeking companies that could provide a sustainable and growing payout over time.
I believe that these dividend stocks could hit both of these targets. Here’s why I’m considering buying them for my portfolio.
Stelrad Group
As a manufacturer and seller of radiators, profits at Stelrad Group are highly sensitive to the broader economic environment. Revenues here dropped 8.9% in the six months to June as tough economic conditions endured.
While it’s not out of the woods yet, signs of improvement in its UK and European territories provide cause for optimism. I’m especially excited by the company’s earnings prospects in its home market as the government takes steps to supercharge home construction.
Demand for Stelrad’s products could rise sharply if the government meets its objective of 300,000 new homes by 2029. Remember though, there remain significant hurdles to making these plans a reality.
In the meantime, the radiator maker looks in good shape to continue raising the dividend. It hiked the interim payout for 2024 by 2%, to 2.98p per share, citing in part “confidence in the group’s future growth prospects and increasing cash generation”.
With leverage of below 1.5 times, it could afford to continue paying a large dividend in 2025 even if market conditions remain tough.
Supermarket Income REIT
Investors should look beyond growth stocks if Fed lowers rates, says Vahan Janjigian
Supermarket Income REIT’s another high-yield stock I’m considering buying to hold for the long term.
More recently, this real estate investment trust (REIT) also expanded into France to give earnings an extra boost.
The business doesn’t just let out its properties to any old retailer either. Its tenants are blue-chip grocers like Tesco, Sainsbury and Marks & Spencer. So it doesn’t have to worry about rent collection issues that could impact its ability to pay dividends.
As a REIT, Supermarket Income has to pay out 90% of annual rental profit to its shareholders. So unless earnings fall off a cliff, investors can expect to receive a tasty payout each year.
Please note that tax treatment depends on the individual circumstances of each client and may be subject to change in future. The content in this article is provided for information purposes only. It is not intended to be, neither does it constitute, any form of tax advice.
On the downside, higher interest rates have taken a bite out of earnings more recently. But with inflation falling, there’s a good chance this will become less of a threat looking ahead.
This is Money highlights the ace up Lowland’s sleeve, while Questor thinks conditions could be ripe for a new bull market in healthcare and that Polar Capital Global Healthcare could be the way to play it.
Frank Buhagiar•03 Sep
This is Money: Lowland Investors Bag 26% in a Year – Can the UK Stock Market Revival Boost It Further?
It’s been a good year for Lowland (LWI) shareholders – the share price is up 26% on the back of a buoyant UK stock market. But such a strong gain in a relatively short time frame poses a dilemma, what to do? Take the money and run or hold on for more? In short, stick or twist? Ask the fund’s managers and they believe there could be more to come. Well, they would say that wouldn’t they? But the explanation they offer up could have legs.
That’s because, as joint manager Laura Foll highlights in the above article, the gains made over the last 12 months have primarily been driven by the equity income fund’s FTSE 100 holdings – top-tier names, including Aviva (up 31 per cent) and Barclays (up 58 per cent), account for around 40% of the trust’s portfolio. And that’s the nub. Less than half the portfolio is in FTSE 100 stocks. As the managers point out, “there is more to come if the recovery in equity prices extends to the domestically focused companies that feature prominently in its portfolio.” Domestically focused companies are typically found in the mid and small-cap space. And, according to Foll, “UK equities are still cheap, especially smaller and medium sized companies.”
Share prices can stay cheap for a long time but, as Foll points out, “we are seeing signs that the UK economy is performing better than the market thought it would. OK, it’s not stellar growth. But this is good news for the small and medium sized businesses we own that generate most of their revenues here in the UK. A stronger economy means improved business revenues.” And even if smaller companies take their time in joining the party, at least shareholders can enjoy “Lowland’s ace up its sleeve” – an attractive 4.8% dividend yield. For LWI’s dividends have proved reliable over the years – the payout has been raised in absolute terms for 14 consecutive years – and has never been cut since LWI was launched and that was way back in 1963.
Questor: Subcontract Your Healthcare Investing Decisions to this Team of Scientists
The above Telegraph article kicks off with a piece of advice – don’t invest in something you don’t understand. That’s not to say investors ought to avoid sectors in which they have limited knowledge. For they could always outsource investment decision-making to a fund run by those in the know. Take biotech and healthcare, a sector where the science can be hard to get a handle on. Step up Polar Capital Global Healthcare (PCGH), a fund managed by a team of scientists and specialist healthcare investors. Unlike some of its peers, PCGH invests across the healthcare spectrum, not just biotech. The result, a high-conviction portfolio diversified by industry sub-sector, geography and company size. It’s a portfolio that has performed. Over the seven years to July 2024, the £475m fund has beaten the MSCI All Countries World Health Care Index by around 12 percentage points.
Questor goes on to build an investment case for the sector: biotech stocks have yet to recover fully from their post-pandemic slump which is leading to a surge in M&A activity; the deployment of AI is driving innovation; demand from emerging markets is growing; and advancements are being made in the treatment of previously incurable diseases. Such is the pace of innovation, that conditions could be ripe for a new bull market in healthcare.
And Questor thinks PCGH “is well positioned for the ongoing recovery of the sector, and sufficiently diversified to weather the volatility that comes with the territory”. There’s more. The potential for “some corporate action should limit the volatility of the share price discount.” Mention of corporate action refers to next year’s liquidation vote that was built into the fund’s corporate structure. Ahead of the vote, Questor believes there will be some form of corporate action, leading the tipster to conclude that “if for any reason the discount widens from here, the investment case only becomes more attractive. Questor says: Buy”
150% increase in the number of Investment Companies trading at 52-week high discounts! Ok, it’s all relative. Only five names on the list compared to two previously. Still, worthy of a closer look at the funds that make it onto the list this time round.
By Frank Buhagiar•02 Sep
After a three-week abscence the Discount Watch is back. We estimate there to be five investment companies which saw their share prices trade at 52-week high discounts over the course of the week ended Friday 30 August 2024 – three more than the previous week’s two.
Discount Watch 150% increase in the number of Investment Companies trading at 52-week high discounts! Ok, it’s all relative. Only five names on the list compared to two previously. Still, worthy of a closer look at the funds that make it onto the list this time round.
By Frank Buhagiar 02 Sep, 2024
After a three-week abscence the Discount Watch is back. We estimate there to be five investment companies which saw their share prices trade at 52-week high discounts over the course of the week ended Friday 30 August 2024 – three more than the previous week’s two.
JPEL Private Equity and Ceiba Investments, the only funds in London’s investment company space to trade at year-high discounts in weeks 33 and 34, as far as we can tell at least. And both still make it onto the list in week 35, but this time they are joined by three new names: Gore Street Energy Storage (GSF) in renewable energy infrastructure; European Opportunities (EOT) from Europe; and Schroder Capital Global Innovation (INOV) from growth capital.
Starting with GSF, the share price had been trading close to 52-wk highs for some time. A new mark for the year was finally set on 28 August (-45.15% compared to -45.11% previously). This was short lived though as the very next day the company released its latest ESG & Sustainability Report. Good timing for the market must have liked what it read – the share price ticked up +2.2% on the day, enough to narrow that discount to -43.94% and get itself off the year high.
Next up EOT. As with GSF, share price set a new discount high for the year on 28 August. As with GSF, the company responded. This time by buying back its shares. According to EOT’s press release of 30 August, 133,723 ordinary shares were purchased at 899.0368 pence per share. News was good for a +1.8% share price rise and a narrowing in the discount to -10.7%.
INOV’s appearance on the Discount Watch can be traced to the company’s write down of its investment in Reaction Engines. As per the 29 August press release, the holding is to be revalued to £1.4 million as at 30 June 2024 compared to £10.6 million as at 31 December 2023. “The impact on the overall net asset value (NAV) of the Company will be approximately 4.81%.” Share price fell 6.2%, that’s more than the NAV hit highlighted in the announcement. Market overreacting or pricing in a complete write down in the future?
Having researched the criteria, u know the yield and the discount to NAV.
Then only the criteria is the prospect of the current dividend being paid.
Dividend:
· Attractive high dividend yield of c.10%, as at closing share price on 9 August 2024.
· Total dividends declared of 2.10p per ordinary share for the Q1 period ended 30 June 2024 (30 June 2023: 2.08p).
· Target dividend of 8.43p per ordinary share for the year ending 31 March 2025 (31 March 2024: 8.35p).
· Forecasted target dividend cover of between 1.1x-1.3x for the year ending 31 March 2025.
· Total ordinary dividends declared since IPO of £357m.
NESF
The next criteria, can u trust the company guidance and their dividend history.
Let’s assume, I know assume can make an ass out of u and me, but u have to trust the company until u have a reason not to.
The price doesn’t rise over the ten years but falls from here.
a. In nine years time u will have received all your capital back, either to re-invest the dividends or to pay your bills, and u have achieved the holy grail of investing in having a share in your portfolio, that cost u nothing, zero, zilch paying u a dividend of ten percent a year, most probably more. The asset life is currently expected to be around 25 years.
b. The price rises to the net asset value and u have made a gain of 20%, if u took the gain it would depend on at what yield u could re-invest at. If u crystalize the gain u could maybe re-invest back into NESF if the price fell back.
If the price rises 20% the yield will fall but still pays a yield of 8%.
Foresight Solar is pleased to announce the second interim dividend, for the period 31 March 2024 to 30 June 2024, of 2.00 pence per ordinary share. The shares will go ex-dividend on 24 October 2024 and the payment will be made on 22 November 2024 to shareholders on the register as at the close of business on 25 October 2024.
The Board confirms its annual dividend target of 8.00 pence per ordinary share for the 2024 financial year.
What do a UK mid/small-cap investor, a build-to-rent REIT, two aircraft leasing funds and a Japanese smaller companies trust all have in common? They are the latest top-five monthly performers in London’s investment company space.
ByFrank Buhagiar•02 Sep
The Top Five
Crystal Amber (CRS) holds on to top spot on Winterflood’s list of highest monthly movers in the investment company space, AGAIN – shares are up +21.7%, a slight improvement on last week’s +20.9% gain. And that’s despite no news out over the past seven days. Shares still benefiting from a run of good news, including share buybacks and a positive update on Investee company: Morphic Medical. This last highlighted how CRS’ interest in Morphic had been independently valued at around US$75.8m (£59.1m), which potentially increases CRS’ unaudited NAV per share to 172.67p from 117.85p. The news triggered a 20% share price gain on the day. Thing is, the day in question was 31 July 2024, which means the one-month anniversary has been and gone. Share price in need of a further boost otherwise it will likely be goodbye top spot.
PRS REIT (PRSR) comes from nowhere to claim second place. No mystery behind the +18.2% share price gain – a letter. Not just any letter but a requisition letter. As announced by the company, the letter calls for a general meeting at which shareholders will vote to replace two of the five existing independent non-executive Directors, including Chairman, Stephen Smith, with Robert Naylor as non-executive Chairman and Christopher Mills of Harwood Capital Management. Shareholders with a combined interest of 17.3% in the build-to-rent REIT put their signatures to the letter including Harwood itself.
Winterflood thinks “the requisitioning shareholders have particular concerns regarding the management contract extensions announced in July. The inability to terminate the manager until 2029 is considered problematic from a governance perspective.” This one could have further to run.
Doric Nimrod Air 3 (DNA3) drops one place to third despite holding onto the majority of its share price gains – up +14.8% compared to +15.4%. Last week’s news from stablemate Doric Nimrod Air 2’s (DNA2) that it is selling its remaining five Airbus A380-861 aircraft to Emirates for higher than expected still having a positive effect on DNA3. Same goes for DNA2 itself, a +14.6% share price gain on the month good for fourth spot on the list. Both funds still flying high then.
JPMorgan Japan Small Cap Growth & Income (JSGI) completes the top five, courtesy of a +9.6% share price rise. Put this down to the proposed merger with JPMorgan Japanese (JFJ) which was announced on 31 July 2024. Fair to say, it’s not been all plain sailing for JSGI’s share price. Shares initially spiked 8% higher on the day of the announcement only to give these all up and a little more a few days later on 6 August 2024 when markets, and Japan’s in particular, had their mid-summer wobble on the back of US recession fears, higher Japanese interest rates and the unwinding of the carry trade. Ah the heady days of summer – the best of times, the worst of times.
Scottish Mortgage
Scottish Mortgage’s (SMT) share price finished the week ended Friday 30 August 2024 with a monthly loss of -4.2%, that’s down on the -1.7% deficit seen seven days earlier. Similar story with NAV, off -4.3% having previously been down -1.7%. The wider global sector fared much better, down -1.5% although it had been flat on the month. Finger of blame for SMT’s relatively poor showing can perhaps be pointed at Nvidia. The megatech’s share price had a volatile time of it, finishing the week off -3.6% after a disappointing quarterly revenue report – at 9.4% of total assets, Nvidia is SMT’s largest holding.
